NCT02619019View on ClinicalTrials.gov

Effect of Spinal Dexamethasone During Transuretheral Prostatectomy

PHASE2CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Postspinal Shivering
Interventions
DRUG

Dexamethasone

Patients will receive 8 mg of hyperbaric bupivacaine 0.5%, plus 8 mg of dexamethasone intrathecally

DRUG

Pethidine

Patients will receive 8 mg of hyperbaric bupivacaine 0.5%, plus 0.2 mg/kg of pethidine intrathecally

DRUG

Normal saline

Patients will receive 8 mg of hyperbaric bupivacaine 0.5%, plus 2 ml normal saline intrathecally

Trial Locations (1)

71111

Seham Mohamed Moeen Ibrahim, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02619019 - Effect of Spinal Dexamethasone During Transuretheral Prostatectomy | Biotech Hunter | Biotech Hunter